These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29199249)

  • 21. Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive
    Nishi M; Takashio S; Morioka M; Fujiyama A; Nakashima N; Hirakawa K; Hanatani S; Usuku H; Yamamoto E; Kidoh M; Oda S; Gushima R; Matsushita K; Fukushima S; Ueda M; Tsujita K
    Circ J; 2022 Jun; 86(7):1113-1120. PubMed ID: 35599006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating cancer risk from
    Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S
    J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.
    Shetty M
    J Nucl Cardiol; 2021 Apr; 28(2):604-609. PubMed ID: 33655447
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and
    Ochi Y; Kubo T; Nakashima Y; Baba Y; Hirota T; Yamasaki N; Yamashita T; Ueda M; Ando Y; Kitaoka H
    J Cardiol; 2020 Jan; 75(1):12-19. PubMed ID: 31324572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radionuclide Imaging of Cardiac Amyloidosis.
    Joseph V; Julien HM; Bravo PE
    PET Clin; 2021 Apr; 16(2):285-293. PubMed ID: 33589384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
    Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
    J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of an uncommon presentation of
    Ochi Y; Kubo T; Nakashima Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol Cases; 2020 Feb; 21(2):50-53. PubMed ID: 32042354
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
    Asif T; Gomez J; Singh V; Doukky R; Nedeltcheva A; Malhotra S
    J Nucl Cardiol; 2021 Feb; 28(1):104-111. PubMed ID: 32901418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.
    Merli E; Giudice ED; Antonopoulos A; Amadei G; Varani E
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):947-949. PubMed ID: 28155044
    [No Abstract]   [Full Text] [Related]  

  • 31. Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough.
    Hussain M; Collier P; Jaber W
    J Nucl Cardiol; 2021 Apr; 28(2):747-749. PubMed ID: 31858425
    [No Abstract]   [Full Text] [Related]  

  • 32. False-Positive
    Schafer EB; Tushak Z; Trankle CR; Rao K; Cartagena LC; Shah KB
    Circ Heart Fail; 2021 Mar; 14(3):e007558. PubMed ID: 33663232
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial Scintigraphy in Diagnosing Cardiac Transthyretin Amyloidosis.
    Petrovic M; Lopez PD; Eng C; Rashid M
    Tex Heart Inst J; 2022 Jul; 49(4):. PubMed ID: 36006616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
    Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
    Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
    J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible gastrointestinal tract involvement in hereditary transthyretin amyloidosis identified by Technetium-99m pyrophosphate scan.
    Chen J; Tang G
    J Cardiovasc Med (Hagerstown); 2023 Jun; 24(6):373-379. PubMed ID: 37115987
    [No Abstract]   [Full Text] [Related]  

  • 40. Noninvasive risk stratification of patients with transthyretin amyloidosis.
    Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
    JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.